Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Maze Therapeutics, Inc. - Common Stock
(NQ:
MAZE
)
29.52
-0.23 (-0.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
280,001
Open
29.97
Bid (Size)
26.50 (2)
Ask (Size)
32.00 (1)
Prev. Close
29.75
Today's Range
29.00 - 31.93
52wk Range
6.710 - 29.86
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
October 06, 2025
Mr. Hoppenot, a seasoned biotech leader who has driven transformative therapies to market, joins Maze to fuel its evolution into a leading clinical-stage biotech
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Biotech Breakouts: 3 Stocks With Massive Upside Potential
September 17, 2025
Biotech stocks are highly volatile; however, these biotech stocks have key trial results this fall that could spark sharp moves and long-term growth potential
Via
MarketBeat
Performance
YTD
+85.1%
+85.1%
1 Month
+24.7%
+24.7%
3 Month
+77.2%
+77.2%
6 Month
+223.3%
+223.3%
1 Year
+85.1%
+85.1%
More News
Read More
What's going on in today's session
September 11, 2025
Via
Chartmill
Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential
September 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 11, 2025
Via
Benzinga
Which stocks are moving on Thursday?
September 11, 2025
Via
Chartmill
Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday
September 11, 2025
Via
Benzinga
Thursday's session: gap up and gap down stocks
September 11, 2025
Via
Chartmill
Why Maze Therapeutics, Up 51%, Was Shocked By Its Own Test Results
September 11, 2025
Via
Investor's Business Daily
Discover the top movers in Thursday's pre-market session.
September 11, 2025
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 11, 2025
Via
Benzinga
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
September 11, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)
September 11, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
September 02, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027
August 12, 2025
Via
Chartmill
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
August 12, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
July 28, 2025
Via
Benzinga
This Celsius Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
July 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 16, 2025
Via
Benzinga
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
July 10, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
May 29, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 28, 2025
Via
Benzinga
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
May 14, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
May 13, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 25, 2025
Via
Benzinga
Frequently Asked Questions
Is Maze Therapeutics, Inc. - Common Stock publicly traded?
Yes, Maze Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Maze Therapeutics, Inc. - Common Stock trade on?
Maze Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Maze Therapeutics, Inc. - Common Stock?
The ticker symbol for Maze Therapeutics, Inc. - Common Stock is MAZE on the Nasdaq Stock Market
What is the current price of Maze Therapeutics, Inc. - Common Stock?
The current price of Maze Therapeutics, Inc. - Common Stock is 29.52
When was Maze Therapeutics, Inc. - Common Stock last traded?
The last trade of Maze Therapeutics, Inc. - Common Stock was at 10/21/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.